| Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository R Kassanjee, CD Pilcher, SM Keating, SN Facente, E McKinney, MA Price, ... AIDS (London, England) 28 (16), 2439, 2014 | 158 | 2014 |
| Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation MP Busch, CD Pilcher, TD Mastro, J Kaldor, G Vercauteren, W Rodriguez, ... Aids 24 (18), 2763-2771, 2010 | 157 | 2010 |
| Estimating HIV incidence in populations using tests for recent infection: issues, challenges and the way forward TD Mastro, AA Kim, T Hallett, T Rehle, A Welte, O Laeyendecker, ... Journal of HIV AIDS surveillance & epidemiology 2 (1), 1, 2010 | 125 | 2010 |
| HIV incidence in rural South Africa: comparison of estimates from longitudinal surveillance and cross-sectional cBED assay testing T Bärnighausen, C Wallrauch, A Welte, TA McWalter, N Mbizana, ... PLoS One 3 (11), e3640, 2008 | 111 | 2008 |
| A new general biomarker-based incidence estimator R Kassanjee, TA McWalter, T Bärnighausen, A Welte Epidemiology (Cambridge, Mass.) 23 (5), 721, 2012 | 104 | 2012 |
| Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy ET Marinda, J Hargrove, W Preiser, H Slabbert, G Van Zyl, J Levin, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 53 (4), 496-499, 2010 | 103 | 2010 |
| Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes YT Duong, R Kassanjee, A Welte, M Morgan, A De, T Dobbs, ... PloS one 10 (2), e0114947, 2015 | 95 | 2015 |
| HIV treatment as prevention: models, data, and questions—towards evidence-based decision-making HIV Modelling Consortium Treatment as Prevention Editorial Writing Group PLoS Medicine 9 (7), e1001259, 2012 | 95 | 2012 |
| Viral load criteria and threshold optimization to improve HIV incidence assay characteristics-a CEPHIA analysis R Kassanjee, CD Pilcher, MP Busch, G Murphy, SN Facente, SM Keating, ... AIDS (London, England) 30 (15), 2361, 2016 | 90 | 2016 |
| Tuberculosis in a South African prison–a transmission modelling analysis SJ Robertson, SD Lawn, A Welte, LG Bekker, R Wood South African Medical Journal 101 (11), 809-813, 2011 | 89 | 2011 |
| Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making? C Hankins, J Hargrove, B Williams, L Abu Raddad, B Auvert, L Bollinger, ... | 83 | 2009 |
| More and better information to tackle HIV epidemics: towards improved HIV incidence assays Incidence Assay Critical Path Working Group PLoS medicine 8 (6), e1001045, 2011 | 77 | 2011 |
| Evaluating audio computer assisted self-interviews in urban south African communities: evidence for good suitability and reduced social desirability bias of a cross-sectional … R Beauclair, F Meng, N Deprez, M Temmerman, A Welte, N Hens, ... BMC medical research methodology 13, 1-7, 2013 | 76 | 2013 |
| Cost-effectiveness of different strategies to monitor adults on antiretroviral treatment: a combined analysis of three mathematical models D Keebler, P Revill, S Braithwaite, A Phillips, N Blaser, A Borquez, ... The Lancet Global Health 2 (1), e35-e43, 2014 | 66 | 2014 |
| HIV incidence estimation using the BED capture enzyme immunoassay: systematic review and sensitivity analysis T Bärnighausen, TA McWalter, Z Rosner, ML Newell, A Welte Epidemiology, 685-697, 2010 | 64 | 2010 |
| Prevalence of anti-SARS-CoV-2 antibodies among blood donors in Northern Cape, KwaZulu-Natal, Eastern Cape, and Free State provinces of South Africa in January 2021. W Sykes, L Mhlanga, R Swanevelder, TN Glatt, E Grebe, C Coleman, ... Research Square, 2021 | 62 | 2021 |
| Relating recent infection prevalence to incidence with a sub-population of assay non-progressors TA McWalter, A Welte Journal of mathematical biology 60, 687-710, 2010 | 59 | 2010 |
| HIV treatment as prevention: principles of good HIV epidemiology modelling for public health decision-making in all modes of prevention and evaluation W Delva, DP Wilson, L Abu-Raddad, M Gorgens, D Wilson, TB Hallett, ... PLoS Medicine 9 (7), e1001239, 2012 | 53 | 2012 |
| Treatment as prevention: preparing the way B Williams, R Wood, V Dukay, W Delva, D Ginsburg, J Hargrove, ... Journal of the International AIDS Society 14 (1), 1-6, 2011 | 51 | 2011 |
| HIV antibody level as a marker of HIV persistence and low-level viral replication SM Keating, CD Pilcher, V Jain, M Lebedeva, D Hampton, ... The Journal of infectious diseases 216 (1), 72-81, 2017 | 50 | 2017 |
Michael BuschDirector, Blood Systems Research Institute; Professor of Lab Med, UCSFAdresse e-mail validée de bloodsystems.org
